Literature DB >> 18603684

Prevalence of HIV-associated cryptococcal meningitis and utility of microbiological determinants for its diagnosis in a tertiary care center.

Rajeev Thakur1, Smita Sarma, Suman Kushwaha.   

Abstract

CONTEXT: Human immunodeficiency virus (HIV) infection continues to be the most important risk factor for the development of central nervous system (CNS) cryptococcosis, which in turn is an important contributor to morbidity and mortality in HIV-infected patients. Early diagnosis of such patients is the key to their therapeutic success. AIMS: This study was undertaken to find out the prevalence of CNS cryptococcosis and to assess the role of microbiological parameters for its specific diagnosis in HIV-reactive hospitalized patients admitted with meningeal signs in a tertiary care setting.
MATERIALS AND METHODS: A total of 104 patients suspected to be suffering from meningitis/meningoencephalitis were subjected to cerebrospinal fluid (CSF) analysis (including India ink preparation, culture by conventional methods and Bactec MGIT 960 system, antigen detection) and tests for HIV antibodies by standard laboratory operating procedures.
RESULTS: The prevalence of HIV infection in our study group was 12.5% (13/104), while the prevalence of cryptococcal CNS infection in HIV-reactive cohort was 46% (6/13). Additionally, 15.3% (2/13) of the patients from this cohort were positive for Mycobacterium tuberculosis.
CONCLUSIONS: High prevalence of cryptococcal CNS infections in HIV-infected patients underscores the importance of precise and early microbiological diagnosis for better management of such patients.

Entities:  

Mesh:

Year:  2008        PMID: 18603684     DOI: 10.4103/0377-4929.41689

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  7 in total

1.  Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon.

Authors:  J P Dzoyem; F A Kechia; G P Ngaba; P K Lunga; P J Lohoue
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

2.  Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011.

Authors:  Doudou Sow; Roger Clément Tine; Khadime Sylla; Mansata Djiba; Cheikh Tidiane Ndour; Thérèse Dieng; Jean Louis Ndiaye; Babacar Faye; Daouda Ndiaye; Oumar Gaye; Yémou Dieng
Journal:  Mycopathologia       Date:  2013-10-25       Impact factor: 2.574

3.  IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status.

Authors:  Krishanthi Subramaniam; Brian Metzger; Lawrence H Hanau; Alice Guh; Lisa Rucker; Sheila Badri; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

4.  Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A.

Authors:  Ada Rita Florio; Selene Ferrari; Elena De Carolis; Riccardo Torelli; Giovanni Fadda; Maurizio Sanguinetti; Dominique Sanglard; Brunella Posteraro
Journal:  BMC Microbiol       Date:  2011-05-11       Impact factor: 3.605

5.  Cryptococcal meningitis: An under-reported disease from the hills of Uttarakhand: A hospital-based cross-sectional study.

Authors:  Aroop Mohanty; Mohit Bhatia; Ankita Kabi; Kuhu Chatterjee; Neelam Kaistha; Balram Ji Omar; Puneet K Gupta; Pratima Gupta
Journal:  J Family Med Prim Care       Date:  2019-06

6.  Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis.

Authors:  Seke G Y Muzazu; Dawit Getachew Assefa; Christabel Phiri; Tewodros Getinet; Samrawit Solomon; Gizachew Yismaw; Tsegahun Manyazewal
Journal:  Front Med (Lausanne)       Date:  2022-09-08

7.  Prevalence of cryptococcal meningitis among people living with human immunodeficiency virus/acquired immunodeficiency syndrome in a Tertiary Care Hospital, Southern Odisha, India.

Authors:  Muktikesh Dash; Sanghamitra Padhi; Rani Sahu; Jyotirmayee Turuk; Swetalona Pattanaik; Pooja Misra
Journal:  J Nat Sci Biol Med       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.